Graham D A, Mawhinney K A, McShane J, Connor T J, Adair B M, Merza M
Veterinary Sciences Division, Department of Agriculture for Northern Ireland, Belfast.
J Vet Diagn Invest. 1997 Jan;9(1):24-31. doi: 10.1177/104063879700900105.
Commercial enzyme-linked immunosorbent assays (ELISAs) for detection of serum antibodies to bovine viral diarrhea virus (BVDV), parainfluenza-3 virus (PI3V), respiratory syncytial virus (RSV), and infectious bovine rhinotracheitis virus (IBRV) were standardized to give a quantitative result when testing was performed at a single optimum dilution. For each test, serum samples were titrated and their end point titers calculated by an algebraic method directly from a plot of each titration series and also from a regression line fitted to this plot. The corrected optical density (COD) of each sample when tested at dilutions of 1/25, 1/50, and 1/100 was expressed as a percentage of the COD of a positive reference serum included on each plate, this value was the sample/positive (S/P) ratio. For each test, the linear relationship between the S/P ratio obtained at a dilution of 1/25, 1/50, and 1/100 and the end point titer calculated by each method was determined. In each case, the best linear relationship existed when samples were tested at a dilution of 1/100 (r = 0.973 for BVDV, 0.962 for PI3V, 0.961 for RSV, 0.947 for IBRV). From the equation of these lines, an increase in the S/P ratio between acute and convalescent serum samples of 31%, 23%, 21%, and 35% would correspond to a 4-fold rise in ELISA titer to BVDV, PI3V, RSV, and IBRV, respectively. ELISA titers calculated from S/P ratios at 1/100 were significantly related to virus neutralization titers to BVDV, RSV, and IBRV and to hemagglutination inhibition titers to PI3V (P < < 0.001 in all cases). Samples with low S/P ratios had the greatest intraassay and interassay variation. Intraassay reproducibility ranged from 3.5% to 22.3% (coefficient of variation), with a median value of 9.5%. Interassay reproducibility was lower, ranging from 6.0% to 50.6%, with a median of 17.4%.
用于检测牛病毒性腹泻病毒(BVDV)、副流感3型病毒(PI3V)、呼吸道合胞病毒(RSV)和传染性牛鼻气管炎病毒(IBRV)血清抗体的商业酶联免疫吸附测定(ELISA)经过标准化处理,以便在单一最佳稀释度下进行检测时给出定量结果。对于每次检测,对血清样本进行滴定,并通过代数方法直接从每个滴定系列的图以及拟合该图的回归线计算其终点滴度。在1/25、1/50和1/100稀释度下检测时,每个样本的校正光密度(COD)表示为每个平板上包含的阳性参考血清COD的百分比,该值即为样本/阳性(S/P)比值。对于每次检测,确定在1/25、1/50和1/100稀释度下获得的S/P比值与通过每种方法计算的终点滴度之间的线性关系。在每种情况下,当样本在1/100稀释度下检测时存在最佳线性关系(BVDV的r = 0.973,PI3V的r = 0.962,RSV的r = 0.961,IBRV的r = 0.947)。根据这些直线的方程,急性和恢复期血清样本的S/P比值分别增加31%、23%、21%和35%将分别对应于ELISA对BVDV、PI3V、RSV和IBRV滴度升高4倍。根据1/100的S/P比值计算的ELISA滴度与对BVDV、RSV和IBRV的病毒中和滴度以及对PI3V的血凝抑制滴度显著相关(所有情况下P << 0.001)。S/P比值低的样本在批内和批间变异最大。批内重复性范围为3.5%至22.3%(变异系数),中位数为9.5%。批间重复性较低,范围为6.0%至50.6%,中位数为17.4%。